Topiroxostat (Standard)

CAT: 0804-HY-14874R-01Size: 5 mgDry Ice: NoHazardous: No

1 / 1

CAT#:0804-HY-14874R-01Size:5 mg

Selected

24/48H Stock Items & 2 to 6 Weeks non Stock Items.

Quick Request Actions

Description

Topiroxostat (Standard) is the analytical standard of Topiroxostat. This product is intended for research and analytical applications. Topiroxostat (FYX-051) is a potent and orally active xanthine oxidoreductase (XOR) inhibitor with an IC50 value of 5.3 nM and a Ki value of 5.7 nM. Topiroxostat exhibits weak CYP3A4-inhibitory activity (18.6%) . Topiroxostat has the potential for hyperuricemia treatment[1][2].

CAS Number

577778-58-6

Product Name Alternative

FYX-051 (Standard)

UNSPSC

12352005

Target

Cytochrome P450; Reference Standards; Xanthine Oxidase

Type

Reference Standards

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/topiroxostat-standard.html

Smiles

N#CC1=NC=CC(C2=NNC(C3=CC=NC=C3)=N2)=C1

Molecular Formula

C13H8N6

Molecular Weight

248.24

References & Citations

[1]Sato T, et al. Discovery of 3- (2-cyano-4-pyridyl) -5- (4-pyridyl) -1,2,4-triazole, FYX-051 - a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia [corrected]. Bioorg Med Chem Lett. 2009 Nov 1;19 (21) :6225-9.|[2]Matsumoto K, et al. FYX-051: a novel and potent hybrid-type inhibitor of xanthine oxidoreductase. J Pharmacol Exp Ther. 2011 Jan;336 (1) :95-103.

Shipping Conditions

Room temperature

Scientific Category

Reference Standards

Chemical Information

Topiroxostat

Topiroxostat is a selective xanthine oxidase inhibitor developed for treatment and management of hyperuricemia and gout. Xanthine oxidase, or xanthine oxidoreductase (XOR), regulates purine metabolism, and inhibition of the enzyme results in efficacious reduction of serum urate levels. Xanthine oxidase inhibitors are classified into two groups; purine analogs such as [DB00437] and [DB05262], and non-purine agents which includes topiroxostat. While [DB00437] is considered a first-line therapy in treating hyperuricemic conditions, it is often associated with side effects and ineffective in reducing uric acid levels under recommended dosing regimens. Renal complications are major comorbidities that limit the [DB00437] therapy as dose reductions are recommended. Topiroxostat and its metabolites are shown to be unaffected by renal complications, thus may be effective in patients with chronic kidney diseases. Approved for therapeutic use in Japan since 2013, topiroxostat is marketed under the name Topiloric and Uriadec and is orally administered twice daily.

CAS Number	577778-58-6
PubChem CID	5288320
IUPAC Name	4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile
Molecular Formula	C13H8N6
Molecular Weight	248.24
XLogP	1.2
Topological Polar Surface Area	91.1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	2
Heavy Atom Count	19
Formal Charge	0
Complexity	344

SMILES

C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N

InChI

InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)

InChIKey

UBVZQGOVTLIHLH-UHFFFAOYSA-N

Chemical Structure

2D Structure

CAS: 577778-58-6

CID: 5288320

Formula: C13H8N6

MW: 248.24

Interactive 3D Structure

Loading 3D structure...

View on PubChem Raw 3D data

Computed Properties

Property	Value
Molecular Weight	248.24
XLogP3	1.2
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	2
Exact Mass	248.08104428
Monoisotopic Mass	248.08104428
Topological Polar Surface Area	91.1 Å²
Heavy Atom Count	19
Formal Charge	0
Complexity	344
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently-Bonded Unit Count	1
Compound Is Canonicalized	Yes

Related Products

Catalog	Name
HY-14874-01	Topiroxostat
HY-14874S-01	Topiroxostat-d4
HY-P0018R-01	Pepstatin (Standard)
HY-N9271R	Grifolin (Standard)
HY-N7933R-01	Tetracosane (Standard)
HY-N7619R	Xanthopurpurin (Standard)
HY-N7503R	Psoralenoside (Standard)
HY-N7432R-01	DIMBOA (Standard)
HY-N7098R-01	Dihydrojasmone (Standard)
HY-N7089R-01	Benzoyleneurea (Standard)

Alternative Products

Catalog	Name
B1192-10	Topiroxostat
TMIJ-0129-01	Topiroxostat-d4
RM-T161801-01	Topiroxostat Impurity A
CS-T-94273	Topiroxostat ACID
CS-T-94274	Topiroxostat Amide impurity
CS-P-02207	Topiroxostat Impurity 5

Topiroxostat (Standard)

Chemical Information

Related Products

Alternative Products

Popular Products